Incannex Healthcare (IXHL) Assets Average (2021 - 2026)
Incannex Healthcare (IXHL) posted quarterly Assets Average of $77.6 million for Q1 2026, up 468.76% year-on-year from $13.7 million in Q1 2025, and up 1.02% on a QoQ basis from $76.9 million in Q4 2025.
Incannex Healthcare (IXHL) Assets Average (2021 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Assets Average for 5 consecutive years, with $77.6 million the latest figure, recorded in Q1 2026.
- Quarterly Assets Average rose 468.76% year-over-year to $77.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.6 million (up 468.76% YoY) and the FY2025 annual result came in at $18.7 million, down 8.17% from the prior year.
- Assets Average rose to $77.6 million in Q1 2026 per IXHL's latest filing, from $76.9 million in the prior quarter.
- Over the last five years, Assets Average for IXHL reached as high as $77.6 million in Q1 2026 and fell as low as $13.6 million in Q4 2024.
- A 4-year average of $35.8 million and a median of $19.8 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average tumbled 31.07% — and 2026, when it surged 468.76%.
- Year by year, Assets Average stood at $66.5 million in 2022, then plunged by 79.6% to $13.6 million in 2024, then soared by 466.13% to $76.9 million in 2025, then gained by 1.02% to $77.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $77.6 million, $76.9 million, and $49.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 77.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.64 Mn |
| Dec 31, 2025 | 76.86 Mn |
| Sep 30, 2025 | 49.58 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Mar 31, 2025 | 13.65 Mn |
| Dec 31, 2024 | 13.58 Mn |
| Sep 30, 2024 | 16.55 Mn |
| Jun 30, 2024 | 17.15 Mn |
| Mar 31, 2024 | 19.80 Mn |
| Dec 31, 2022 | 66.55 Mn |
| Jun 30, 2022 | 23.60 Mn |
| Jun 30, 2021 | 6.78 Mn |